We have developed the first approach to making T-Cell Priming Vaccines using experimentally-selected purely synthetic non-biological components that programme immune cells to destroy pathogen-producing cells.

These vaccines ‘prime’ the immune systems of recipients to recognise subsequent infectious agents much like a natural infection would do, and thus preventing an acute or severe manifestation of the disease.